期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

加替沙星与左氧氟沙星体外抗菌效果比较 被引量：1

下载PDF
导出
摘要 目的 :比较加替沙星与左氧氟沙星体外抗菌活性、MIC(最低抑菌浓度 ) ,为临床提供依据。方法 :药敏试验采用微量肉汤稀释法。结果 :1 0 2株菌株对加替沙星、左氧氟沙星的敏感百分率分别为 86 3%、83 3% ,统计学处理无显著性差异。结论
作者 李沅湘 张茂林
机构地区 长沙市第四医院 湖北省孝感市第三医院
出处 《湖南中医杂志》 2004年第5期58-59,共2页 Hunan Journal of Traditional Chinese Medicine
关键词 左氧氟沙星 加替沙星 效果比较 体外抗菌 肉汤稀释法 统计学处理 临床 结论 百分率
分类号 R978 [医药卫生—药品] R969 [医药卫生—药理学]
  • 相关文献

参考文献4

二级参考文献26

  • 1周伟澄,张秀平.氟喹诺酮类药物研究的新进展[J].中国医药工业杂志,1997,28(2):75-81. 被引量：35
  • 2[1]Hosaka M,Yaxue T, Fukuda H, Tomizawa H, et al.In vitro and in vivo antibacterial activities of AM-1 155, a new 6-fluoro-8-methoxy quinolone. Antimicrobial Agents Chemotherapy, 1992;36:2108～2117.
  • 3[2]Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methyoxy quinolone. Antimicrobial Agents Chemotherapy, 1994;38:594～601.
  • 4[3]Wise R, Brenwald NP, Andrews JM,et al. The activity of the methylpiperazinyl fluoroquinolone CG5501:A comparison with other fluoroquinolones fluoroquinolones. Antimicrobial Chemotherapy, 1997;39:447～452.
  • 5[4]National Committee for Clinical Laboratory Standards. 1998;18.
  • 6[5]Hosaka M,Kinoshita S, Toyama A,et al. Antibacterial Properties of AM-1155, a new 8-methoxy quinolone. Antimicrobial Chemotherapy, 1995; 36:293～301.
  • 7[6]Tanaka M,Takahashi K, Saika T, et al. Development of fluoroquinoloneresistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae in Japan. Urology, 1998; 159:2215～2219.
  • 8[7]Deguchi T, Yasuda M, Nakano M,ea al. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GryA and ParC.Chemotherapy, 1997;43:239～244.
  • 9[8]Nakashima M,Uematsu T,Kosuge K, et al. Single and multiple-dose pharmacolinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrobial Agents Chemotherapy,1995;39:2635～2640.
  • 10American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia diagnosis, assessment of severity, antimicrobial therapy, and prevention [J]. Am J Resp Crit Care Med, 2001,163:1730

共引文献120

同被引文献10

  • 1Zhang C, Liang Y, Deng S, et al. Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004 [ J]. Clin Ophthalmol, 2008, 2 (3) : 575-579.
  • 2Batzli CL, McCormick CC, Caballero AR, et al. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylo- coccus aureus keratitis[ J]. J Cataract Refract Surg, 2008, 34(2) : 295 -301.
  • 3Chawla B, Agarwal P, Tandon R, et al. In vitro susceptibility of bae- teri keratitis isolates to fourth-generation fluoroquinolones[ J]. EurJ Ophthaimol, 2010, 20(2): 300-305.
  • 4Sanders ME, Norcross EW, Moore 3rd QC, et al. Efficacy of besi- floxacin in a rabbit model of methicillin-resistant Staphylococcus au- reus keratitis[J]. Cornea, 2009, 28(9) : 1055-1060.
  • 5Sanders ME, Moore 3rd QC, Norcross EW, et al. Efficacy of besi- floxacin in an early treatment model of methicillin-resistant Staphylo- coccus aureus keratitis[ J]. J Ocul Pharmaeol Ther, 2010, 26 (2) : 195-198.
  • 6Sueke H, Kaye S, Neal T , et al. Minimum Inhibitory Concentrations of Standard and Novel Antimicrobials for Isolates from Bacterial Kera- titis[J]. Invest. Ophthalmol. Vis Sci, 2010, 51(5) : 2519-2524.
  • 7郭萍,姚晓明,黄丽娜,齐卫,郭金莲.118例感染性角膜炎的回顾性分析[J].中国当代医药,2009,16(6):19-21. 被引量：7
  • 8唐军,刘平羽,周鸣.加替沙星56例不良反应分析[J].药物流行病学杂志,2011,20(1):30-31. 被引量：5
  • 9甄少立,吴小清.三种抗菌滴眼液治疗外眼细菌性感染的临床研究[J].中国实用医药,2011,6(20):120-121. 被引量：7
  • 10孙声桃,王丽娅,张月琴,陈祖基,韩雷,岳娟.近六年眼部分离细菌及体外药物敏感性的变迁[J].中华眼科杂志,2012,48(6):542-547. 被引量：9

引证文献1

二级引证文献15

湖南中医杂志
2004年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部